Mir Ali, MD, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in California, who was not involved in the Eli Lilly study, told Healthline that while all GLP-1 drugs can work regardless of extra medical conditions, there are some unique aspects to Zepbound
conversely, GI-sensitive individuals may benefit from semaglutide's single-target approach
When a drug like Wegovy is in short supply, section 503A of the Federal Food, Drug, and Cosmetic Act allows for the compounding of essentially a copy of the approved drug
"Its worst the second day after the injection because thats when the medicine peaks." JudgeEconomy8923 3
Lilly Scores Win in Smaller Oral Type 2 Diabetes Market Lilly also released some positive news regarding its developmental oral GLP-1, orforglipron